Source link : https://www.newshealth.biz/health-news/telomerase-inhibitor-approved-for-mds-related-anemia/
The FDA approved imetelstat (Rytelo) for adults with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia who failed or cannot take standard treatment, the agency announced late on Thursday. An oligonucleotide telomerase inhibitor, imetelstat is specifically indicated for use in MDS patients requiring at least four red blood cell units over 8 weeks […]
Author : News Health
Publish date : 2024-06-07 13:30:56
Copyright for syndicated content belongs to the linked Source.
Categories